Clinical Trial Update: Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for sub-lingual dexmedetomidine in agitation associated with dementia, spanning Phase 1 and Phase 2; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation
• Dementia

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Sub-Lingual Dexmedetomidine

Snippet

Sponsor: BioXcel Therapeutics Inc | Conditions: Agitation,Psychomotor, Dementia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-21